Why approved Chinese-developed GMO rice that boosts yields, reduces pesticide use not available to country’s farmers, consumers

b f b

In 2009, two insect-resistant genetically modified rice lines (Huahui-1 and Bt-Shanyou -63) were granted biosafety certificates by the Ministry of Agriculture (MOA) in China after nearly 10 years of rigorous and strict biosafety assessments. Most farmers welcomed the planting of the transgenic rice due to their potential to reduce pesticide spraying by 50-60%, increase yield by 60-65% and improve the health of farmers. [However,] these two lines have yet [to be] commercialized … largely because of low public acceptance. … This has created a dilemma. On the one hand, the government has invested substantial amounts of funding in GM crop development, but on the other hand, the end users or consumers are not prepared to accept GM products due to safety reasons.

Public worries still exist simply because the protocols of the technology remains too technical to be understood. Consumers often do not have access to appropriate channels providing science-based and easy-to-understand information. Consequently, they are misled by activists from non-governmental organizations (NGOs) which utilizes the social media reports to publicize the misconception of GM crops. The outreach of scientists in educating the public with essential knowledge of transgenic biotechnology, its benefits derived and biosafety issues is crucially needed in order to bring notable impact to the public’s acceptance of GM crops.

Read full, original post: Producing Transgenic Rice with Improved Traits and Yield — How Far Have We Come?

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-09-10-at-11.50.46-AM
Did COVID vaccines kill 2,500 service members? RFK Jr. hires an investigator who compares vaccine promoters to Nazi doctors
ChatGPT-Image-Sep-13-2026-10_24_17-AM
Bayer urges court to approve $7.25 billion Monsanto Roundup settlement that could limit its future liabilities
ChatGPT-Image-Sep-15-2026-06_05_13-PM
CRISPR fine-tuning unlocks vitamin C-rich potatoes without yield loss
Screenshot-2026-09-10-at-12.20.19-PM
'Jet fuel didn't melt the steel': 9/11 conspiracy theories debunked
ChatGPT-Image-Sep-15-2026-05_59_18-PM
RFK Jr. spent two years distancing himself from Children’s Health Defense. Now he’s keynoting its anti-vaccine DC conference.
ChatGPT-Image-Aug-28-2026-03_33_46-PM
Viewpoint: Bad science—Five bogus Trump administration claims about vaccines and autism
Screenshot-2026-09-11-at-2.26.23-PM
Newly approved GMO chestnut trees planted across from the White House are stirring debate
ChatGPT-Image-Sep-2-2026-10_30_14-PM
Zero: That is the official American measles death toll for 2026. Here is what RFK Jr.’s CDC leaves out.
Screenshot-2026-09-14-at-10.52.30-AM
AI is being used in dangerous bioscience experiments
ChatGPT-Image-Sep-14-2026-11_36_25-AM
How the reckless AI race among Anthropic, OpenAI and China spawned today’s safety crisis
Screenshot 2026-09-10 at 11.28
A meaty problem: How to make cell-grown protein taste like steak, chicken, and seafood
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.